» Articles » PMID: 38887560

Cancer Predisposing Syndromes in Childhood and Adolescence Pose Several Challenges Necessitating Interdisciplinary Care in Dedicated Programs

Overview
Journal Front Pediatr
Specialty Pediatrics
Date 2024 Jun 18
PMID 38887560
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Genetic disposition is a major etiologic factor in childhood cancer. More than 100 cancer predisposing syndromes (CPS) are known. Surveillance protocols seek to mitigate morbidity and mortality. To implement recommendations in patient care and to ascertain that the constant gain of knowledge forces its way into practice specific pediatric CPS programs were established.

Patients And Methods: We retrospectively analyzed data on children, adolescents, and young adults referred to our pediatric CPS program between October 1, 2021, and March 31, 2023. Follow-up ended on December 31, 2023.

Results: We identified 67 patients (30 male, 36 female, 1 non-binary, median age 9.5 years). Thirty-five patients were referred for CPS surveillance, 32 for features suspicious of a CPS including café-au-lait macules ( = 10), overgrowth ( = 9), other specific symptoms ( = 4), cancer suspicious of a CPS ( = 6), and rare neoplasms ( = 3). CPS was confirmed by clinical criteria in 6 patients and genetic testing in 7 (of 13). In addition, 6 clinically unaffected at-risk relatives were identified carrying a cancer predisposing pathogenic variant. A total of 48 patients were eventually diagnosed with CPS, surveillance recommendations were on record for 45. Of those, 8 patients did not keep their appointments for various reasons. Surveillance revealed neoplasms ( = 2) and metachronous tumors ( = 4) by clinical ( = 2), radiological examination ( = 2), and endoscopy ( = 2). Psychosocial counselling was utilized by 16 (of 45; 35.6%) families.

Conclusions: The diverse pediatric CPSs pose several challenges necessitating interdisciplinary care in specified CPS programs. To ultimately improve outcome including psychosocial well-being joint clinical and research efforts are necessary.

Citing Articles

Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician.

Kuhlen M, Weins A, Stadler N, Angelova-Toshkina D, Fruhwald M World J Pediatr. 2024; 21(2):131-148.

PMID: 39641826 PMC: 11885337. DOI: 10.1007/s12519-024-00853-8.

References
1.
Rowland E, Metcalfe A . Communicating inherited genetic risk between parent and child: a meta-thematic synthesis. Int J Nurs Stud. 2012; 50(6):870-80. DOI: 10.1016/j.ijnurstu.2012.09.002. View

2.
Rao J, Engelke U, Sweep F, Pacak K, Kusters B, Goudswaard A . Genotype-specific differences in the tumor metabolite profile of pheochromocytoma and paraganglioma using untargeted and targeted metabolomics. J Clin Endocrinol Metab. 2014; 100(2):E214-22. PMC: 5393507. DOI: 10.1210/jc.2014-2138. View

3.
Mindrup R . Imprints of "Scanxiety". AMA J Ethics. 2022; 24(7):E685-693. DOI: 10.1001/amajethics.2022.685. View

4.
Brodeur G, Nichols K, Plon S, Schiffman J, Malkin D . Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr. Clin Cancer Res. 2017; 23(11):e1-e5. PMC: 5553563. DOI: 10.1158/1078-0432.CCR-17-0702. View

5.
Fruhwald M, Nemes K, Boztug H, Cornips M, Evans D, Farah R . Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group. Fam Cancer. 2021; 20(4):305-316. PMC: 8484234. DOI: 10.1007/s10689-021-00229-1. View